BDX 130.34 Becton Dickinson and Company $BDX Hit a
Post# of 72
BDX Recent Posts: http://investorshangout.com/Becton-Dickinson-...BDX-50260/
BDX Becton Dickinson and Company Recent Headline News
Becton Dickinson Set to Possibly Pullback After Yesterday's Rally of 1.08%
Comtex SmarTrend(R) - Tue Nov 18, 5:04PM CST
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $129.25 to a high of $131.15. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 130.22 (-0.72)
Look for Shares of Becton Dickinson to Potentially Pullback after Yesterday's 1.08% Rise
Comtex SmarTrend(R) - Tue Nov 18, 5:03PM CST
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $129.25 to a high of $131.15. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 130.22 (-0.72)
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - Tue Nov 18, 10:47AM CST
There's a powerful collection of 'what's working.'
HON: 96.29 (-0.54), JAH: 67.68 (+0.65), CAH: 80.42 (-0.59), WMT: 84.63 (+0.84), PDCO: 46.66 (+0.05), EAT: 54.17 (+0.20), UPS: 105.53 (-0.50), JACK: 74.76 (+3.26), DLTR: 61.77 (-0.22), TGT: 71.10 (+3.59), COST: 139.67 (+0.46), AAL: 44.65 (-0.40), DG: 63.76 (-2.41), LOW: 61.98 (+3.45), MSFT: 48.07 (-0.67), HSIC: 132.06 (-0.33), BCR: 166.11 (-1.25), MCK: 206.03 (-1.96), IP: 54.58 (-0.40), EW: 126.75 (-1.13), FDO: 78.24 (-0.61), AZO: 569.97 (+1.38), MCD: 97.10 (+0.69), SHW: 240.36 (-0.96), XRAY: 53.02 (-0.09), AN: 57.98 (+0.25), F: 15.36 (-0.14), ACT: 265.14 (-4.46), BDX: 130.22 (-0.72), VRX: 142.70 (+0.76), MDT: 72.09 (-0.38), SNA: 135.37 (-0.65), GMCR: 156.13 (-0.97), AGN: 212.24 (-1.13), KMX: 55.25 (+0.12), YHOO: 50.78 (-0.97), WHR: 178.16 (+0.94), CMG: 657.68 (-0.41), AAPL: 114.43 (-1.04), AMZN: 326.28 (+1.35), HD: 96.48 (+0.50), ORLY: 178.87 (+0.30), FRGI: 56.10 (+0.08), ABC: 89.12 (-0.64), TJX: 62.05 (+0.41), GM: 32.14 (-0.13), JWN: 73.34 (-0.18), ROST: 81.65 (+0.37)
Why Baxter Has An Attractive Economic Castle
Valuentum - at Seeking Alpha - Tue Nov 18, 7:11AM CST
BSX: 13.54 (-0.14), BDX: 130.22 (-0.72), BAX: 72.50 (-0.08)
Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:10PM CST
Covidien plc (COV) recently announced six-month results from the VeClose pivotal study, which was carried out to evaluate the safety and efficiency of the VenaSeal closure system, a treatment option for chronic venous disorders.
JNJ: 108.12 (-0.71), BDX: 130.22 (-0.72), BCR: 166.11 (-1.25), COV: 98.06 (-0.03)
Would You Pay More Or Less For 10% More Income?
Eli Inkrot - at Seeking Alpha - Mon Nov 17, 1:33PM CST
KO: 44.11 (+0.58), KMI: 40.54 (+0.13), T: 35.40 (-0.32), JNJ: 108.12 (-0.71), BDX: 130.22 (-0.72), IBM: 161.71 (-0.18), WMT: 84.63 (+0.84), MCD: 97.11 (+0.70), BP: 41.27 (+0.08), PG: 88.29 (+0.34), CVX: 115.74 (+0.27), CL: 67.95 (-0.02)
InvestorsObserver releases comments on Home Depot, Becton Dickinson, Foot Locker, Toll Brothers, and GameStop
PR Newswire - Mon Nov 17, 8:31AM CST
InvestorsObserver.com releases its Stocks To Watch guide.
BDX: 130.22 (-0.72), HD: 96.47 (+0.49), GME: 43.56 (-0.46), FL: 54.89 (+0.06), TOL: 33.90 (+0.01)
Dividend Champions: 11 Increases Expected By The End Of January
David Fish - at Seeking Alpha - Sun Nov 16, 10:18AM CST
T: 35.40 (-0.32), VAL: 84.61 (-0.08), BDX: 130.22 (-0.72), MKC: 72.54 (+0.04), NUE: 53.33 (-1.03), SYY: 39.17 (+0.03), LANC: 92.34 (-0.08), HRL: 55.29 (+0.18), BEN: 56.08 (-0.30), BF.B: 93.75 (-0.33), ABM: 26.86 (-0.20)
Evaluating Mettler-Toledo's Valuation
Valuentum - Seeking Alpha - Sat Nov 15, 7:09AM CST
The stock market is one of the most misunderstood concepts in the human brain. Investing is not about buying and holding (and praying for an idea to work out over the long run). Investing for wealth will always be about identifying mispriced...
BDX: 130.22 (-0.72), BAX: 72.50 (-0.08), MTD: 290.85 (-0.80)
Becton, Dickinson Ordered to Clarify False Syringe Claims - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 12:40PM CST
Becton, Dickinson and Co (BDX) recently received an unfavorable ruling with respect to its lawsuit against Retractable Technologies Inc.
ABC: 89.12 (-0.64), BDX: 130.22 (-0.72), STE: 62.76 (-0.15), MMSI: 14.64 (-0.16)
District court judge doesn't give Retractable Tech all it sought in BD case
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 12:27PM CST
BDX: 130.22 (-0.72), RVP: 4.32 (+0.09)
Update: Retractable Technologies Wins In Syringe Antitrust Suit
Dutch Trader - at Seeking Alpha - Tue Nov 11, 11:32PM CST
BDX: 130.22 (-0.72), RVP: 4.32 (+0.09)
BD to Present at the Stifel 2014 Healthcare Conference
PR Newswire - Tue Nov 11, 3:30PM CST
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Stifel 2014 Healthcare Conference on Tuesday, November 18, at 10:20 a.m. ET.
BDX: 130.22 (-0.72)
Becton, Dickinson: Let's Do A Check-Up On Its Fiscal 2014 Earnings
David Schauber, Jr. - at Seeking Alpha - Tue Nov 11, 10:34AM CST
BDX: 130.22 (-0.72)
The Best Offense Is A Good Defense
Eric Parnell, CFA - Seeking Alpha - Sat Nov 08, 8:36AM CST
What a difference a few weeks make. Stocks are once again in rally mode and bullishness is back on the street. After bottoming back on October 15, stocks as measured by the S&P 500 Index have rallied an impressive +11.6% to advance to fresh new...
XLB: 49.72 (-0.15), BDX: 130.22 (-0.72), SPLV: 37.04 (-0.10), DAL: 44.31 (-0.48), XLY: 69.42 (+0.09), BBY: 35.08 (+0.18), XLU: 45.54 (-0.12), SO: 47.14 (-0.11), XLV: 68.23 (-0.44), YHOO: 50.77 (-0.98), XLP: 48.37 (+0.11), SPY: 204.73 (-0.82), SPHB: 34.24 (-0.22), XLK: 41.35 (-0.32), PG: 88.29 (+0.34), XLI: 56.39 (-0.26), XLE: 85.76 (-0.07)
SmarTrend Watching for Potential Rebound in Shares of Becton Dickinson After 1.87% Loss
Comtex SmarTrend(R) - Fri Nov 07, 4:07PM CST
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $125.35 to a high of $128.20. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $125.94 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 130.22 (-0.72)
Becton Dickinson Falls 1.87% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Nov 07, 4:07PM CST
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $125.35 to a high of $128.20. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $125.94 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 130.22 (-0.72)
CareFusion Q1 Earnings, Revenues Rise and Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
CareFusion Corporation (CFN) now expects adjusted earnings to increase in the range of $2.80-$2.95 per share, higher than the earlier band of $2.60-$2.75 per share.
BDX: 130.22 (-0.72), BCR: 166.11 (-1.25), BAX: 72.50 (-0.08), CFN: 57.75 (-0.03)
Dividend Growth Strategy: Take The Beaten Path Or Road Less Traveled?
Adam Aloisi - at Seeking Alpha - Thu Nov 06, 1:52PM CST
KO: 44.11 (+0.58), BDX: 130.22 (-0.72), HD: 96.49 (+0.51), AMT: 100.37 (-0.28), AMGN: 161.40 (-0.84), O: 46.25 (+0.14), MO: 49.15 (-0.12), CSX: 36.55 (-0.12), LUV: 39.24 (-0.43), T: 35.39 (-0.33), JNJ: 108.12 (-0.71), RCL: 70.33 (+0.51), V: 248.60 (-1.13), QCOM: 70.97 (-1.04), MCD: 97.11 (+0.70), PG: 88.29 (+0.34), MSFT: 48.07 (-0.67), CVX: 115.74 (+0.27), AAPL: 114.44 (-1.03), WAG: 67.86 (-0.20)
Techne on an Acquisition Spree, Buys CyVek for $60M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:41PM CST
Techne Corp. (TECH) intends to leverage CyPlex, CyVek's breakthrough technology to derive maximum value from its extensive reagents portfolio.
GE: 26.88 (-0.13), BDX: 130.22 (-0.72), TMO: 123.48 (+2.98), TECH: 90.10 (-0.26)